nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminosalicylic Acid—PTGS2—pancreatic cancer	0.538	1	CbGaD
Aminosalicylic Acid—MPO—superior mesenteric artery—pancreatic cancer	0.0733	0.727	CbGeAlD
Aminosalicylic Acid—CHUK—digestive system—pancreatic cancer	0.00474	0.047	CbGeAlD
Aminosalicylic Acid—ALOX5—islet of Langerhans—pancreatic cancer	0.00445	0.0441	CbGeAlD
Aminosalicylic Acid—ALOX5—pancreas—pancreatic cancer	0.00313	0.031	CbGeAlD
Aminosalicylic Acid—ALOX5—digestive system—pancreatic cancer	0.00267	0.0265	CbGeAlD
Aminosalicylic Acid—MPO—pancreas—pancreatic cancer	0.00265	0.0263	CbGeAlD
Aminosalicylic Acid—PTGS2—gall bladder—pancreatic cancer	0.00261	0.0258	CbGeAlD
Aminosalicylic Acid—MPO—digestive system—pancreatic cancer	0.00226	0.0224	CbGeAlD
Aminosalicylic Acid—PTGS2—islet of Langerhans—pancreatic cancer	0.00171	0.0169	CbGeAlD
Aminosalicylic Acid—Mesalazine—PPARG—pancreatic cancer	0.00161	0.443	CrCbGaD
Aminosalicylic Acid—Pericarditis—Doxorubicin—pancreatic cancer	0.00144	0.00861	CcSEcCtD
Aminosalicylic Acid—Dermatitis atopic—Docetaxel—pancreatic cancer	0.00134	0.00806	CcSEcCtD
Aminosalicylic Acid—Hypoglycaemia—Sunitinib—pancreatic cancer	0.0013	0.00779	CcSEcCtD
Aminosalicylic Acid—PTGS2—pancreas—pancreatic cancer	0.0012	0.0119	CbGeAlD
Aminosalicylic Acid—Weight decreased—Tamoxifen—pancreatic cancer	0.00116	0.00694	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Erlotinib—pancreatic cancer	0.00115	0.00687	CcSEcCtD
Aminosalicylic Acid—Dermatitis exfoliative—Irinotecan—pancreatic cancer	0.00111	0.00664	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Erlotinib—pancreatic cancer	0.00111	0.00663	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Sunitinib—pancreatic cancer	0.0011	0.00662	CcSEcCtD
Aminosalicylic Acid—Eruption—Epirubicin—pancreatic cancer	0.00109	0.00654	CcSEcCtD
Aminosalicylic Acid—Optic neuritis—Epirubicin—pancreatic cancer	0.00109	0.00654	CcSEcCtD
Aminosalicylic Acid—PTGS1—digestive system—pancreatic cancer	0.00107	0.0106	CbGeAlD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Irinotecan—pancreatic cancer	0.00105	0.00626	CcSEcCtD
Aminosalicylic Acid—PTGS2—digestive system—pancreatic cancer	0.00103	0.0102	CbGeAlD
Aminosalicylic Acid—Hepatitis—Tamoxifen—pancreatic cancer	0.00103	0.00614	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Erlotinib—pancreatic cancer	0.00101	0.00608	CcSEcCtD
Aminosalicylic Acid—Optic neuritis—Doxorubicin—pancreatic cancer	0.00101	0.00605	CcSEcCtD
Aminosalicylic Acid—Eruption—Doxorubicin—pancreatic cancer	0.00101	0.00605	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Erlotinib—pancreatic cancer	0.001	0.006	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Fluorouracil—pancreatic cancer	0.001	0.006	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Erlotinib—pancreatic cancer	0.000994	0.00596	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Sunitinib—pancreatic cancer	0.000992	0.00595	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Sunitinib—pancreatic cancer	0.000959	0.00574	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Irinotecan—pancreatic cancer	0.00091	0.00545	CcSEcCtD
Aminosalicylic Acid—Dermatitis atopic—Epirubicin—pancreatic cancer	0.000907	0.00543	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Erlotinib—pancreatic cancer	0.000883	0.00529	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Sunitinib—pancreatic cancer	0.000878	0.00526	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Tamoxifen—pancreatic cancer	0.000874	0.00524	CcSEcCtD
Aminosalicylic Acid—Flatulence—Erlotinib—pancreatic cancer	0.00087	0.00521	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Sunitinib—pancreatic cancer	0.000867	0.00519	CcSEcCtD
Aminosalicylic Acid—Diflunisal—PTGS2—pancreatic cancer	0.000865	0.238	CrCbGaD
Aminosalicylic Acid—Urethral disorder—Sunitinib—pancreatic cancer	0.000861	0.00516	CcSEcCtD
Aminosalicylic Acid—Dermatitis atopic—Doxorubicin—pancreatic cancer	0.000839	0.00503	CcSEcCtD
Aminosalicylic Acid—Anaemia—Tamoxifen—pancreatic cancer	0.000825	0.00494	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Irinotecan—pancreatic cancer	0.000817	0.0049	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Tamoxifen—pancreatic cancer	0.000799	0.00479	CcSEcCtD
Aminosalicylic Acid—Jaundice—Irinotecan—pancreatic cancer	0.000785	0.0047	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Gemcitabine—pancreatic cancer	0.000769	0.00461	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Sunitinib—pancreatic cancer	0.000764	0.00458	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Fluorouracil—pancreatic cancer	0.000756	0.00453	CcSEcCtD
Aminosalicylic Acid—Flatulence—Sunitinib—pancreatic cancer	0.000753	0.00451	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Sunitinib—pancreatic cancer	0.000748	0.00448	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—pancreatic cancer	0.000746	0.00447	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Gemcitabine—pancreatic cancer	0.000732	0.00439	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Docetaxel—pancreatic cancer	0.000723	0.00433	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Fluorouracil—pancreatic cancer	0.00072	0.00431	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.000713	0.00427	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Erlotinib—pancreatic cancer	0.000707	0.00423	CcSEcCtD
Aminosalicylic Acid—Anaemia—Sunitinib—pancreatic cancer	0.000706	0.00423	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Erlotinib—pancreatic cancer	0.000705	0.00423	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Erlotinib—pancreatic cancer	0.0007	0.00419	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Gemcitabine—pancreatic cancer	0.000696	0.00417	CcSEcCtD
Aminosalicylic Acid—Anorexia—Tamoxifen—pancreatic cancer	0.000694	0.00416	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Gemcitabine—pancreatic cancer	0.000691	0.00414	CcSEcCtD
Aminosalicylic Acid—Anorexia—Erlotinib—pancreatic cancer	0.000687	0.00411	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Sunitinib—pancreatic cancer	0.000684	0.0041	CcSEcCtD
Aminosalicylic Acid—Mesalazine—PTGS2—pancreatic cancer	0.000679	0.187	CrCbGaD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.000646	0.00387	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Tamoxifen—pancreatic cancer	0.000633	0.00379	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.000629	0.00377	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Erlotinib—pancreatic cancer	0.000626	0.00375	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.000622	0.00373	CcSEcCtD
Aminosalicylic Acid—Flatulence—Irinotecan—pancreatic cancer	0.00062	0.00372	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Sunitinib—pancreatic cancer	0.000612	0.00366	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Sunitinib—pancreatic cancer	0.000611	0.00366	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Sunitinib—pancreatic cancer	0.000606	0.00363	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.000595	0.00357	CcSEcCtD
Aminosalicylic Acid—Anorexia—Sunitinib—pancreatic cancer	0.000595	0.00356	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.000589	0.00353	CcSEcCtD
Aminosalicylic Acid—Anaemia—Irinotecan—pancreatic cancer	0.000582	0.00349	CcSEcCtD
Aminosalicylic Acid—Urticaria—Tamoxifen—pancreatic cancer	0.000579	0.00347	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Tamoxifen—pancreatic cancer	0.000576	0.00345	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Erlotinib—pancreatic cancer	0.00057	0.00341	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Erlotinib—pancreatic cancer	0.00057	0.00341	CcSEcCtD
Aminosalicylic Acid—Anaemia—Gemcitabine—pancreatic cancer	0.000567	0.0034	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Docetaxel—pancreatic cancer	0.000565	0.00339	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Irinotecan—pancreatic cancer	0.000564	0.00338	CcSEcCtD
Aminosalicylic Acid—Anaemia—Fluorouracil—pancreatic cancer	0.000557	0.00334	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Gemcitabine—pancreatic cancer	0.000549	0.00329	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Docetaxel—pancreatic cancer	0.000546	0.00327	CcSEcCtD
Aminosalicylic Acid—Vascular purpura—Epirubicin—pancreatic cancer	0.000545	0.00326	CcSEcCtD
Aminosalicylic Acid—Jaundice—Docetaxel—pancreatic cancer	0.000543	0.00325	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Sunitinib—pancreatic cancer	0.000542	0.00325	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Fluorouracil—pancreatic cancer	0.00054	0.00323	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000538	0.00323	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000537	0.00321	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Docetaxel—pancreatic cancer	0.00052	0.00311	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000518	0.00311	CcSEcCtD
Aminosalicylic Acid—Dermatitis exfoliative—Epirubicin—pancreatic cancer	0.000517	0.00309	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.00051	0.00306	CcSEcCtD
Aminosalicylic Acid—Purpura—Epirubicin—pancreatic cancer	0.000506	0.00303	CcSEcCtD
Aminosalicylic Acid—Vascular purpura—Doxorubicin—pancreatic cancer	0.000504	0.00302	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Irinotecan—pancreatic cancer	0.000504	0.00302	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000503	0.00301	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Docetaxel—pancreatic cancer	0.0005	0.003	CcSEcCtD
Aminosalicylic Acid—Hypoglycaemia—Epirubicin—pancreatic cancer	0.000499	0.00299	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Tamoxifen—pancreatic cancer	0.000498	0.00299	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Docetaxel—pancreatic cancer	0.000494	0.00296	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Sunitinib—pancreatic cancer	0.000493	0.00295	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Sunitinib—pancreatic cancer	0.000493	0.00295	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Erlotinib—pancreatic cancer	0.000493	0.00295	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000491	0.00294	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Docetaxel—pancreatic cancer	0.00049	0.00294	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.00049	0.00294	CcSEcCtD
Aminosalicylic Acid—Anorexia—Irinotecan—pancreatic cancer	0.00049	0.00293	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Epirubicin—pancreatic cancer	0.000487	0.00292	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Gemcitabine—pancreatic cancer	0.000486	0.00291	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000483	0.00289	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000482	0.00289	CcSEcCtD
Aminosalicylic Acid—Dizziness—Tamoxifen—pancreatic cancer	0.000482	0.00289	CcSEcCtD
Aminosalicylic Acid—Salicylic acid—PTGS2—pancreatic cancer	0.000481	0.132	CrCbGaD
Aminosalicylic Acid—Dermatitis exfoliative—Doxorubicin—pancreatic cancer	0.000478	0.00286	CcSEcCtD
Aminosalicylic Acid—Anorexia—Gemcitabine—pancreatic cancer	0.000477	0.00286	CcSEcCtD
Aminosalicylic Acid—Dizziness—Erlotinib—pancreatic cancer	0.000476	0.00285	CcSEcCtD
Aminosalicylic Acid—Anorexia—Fluorouracil—pancreatic cancer	0.000469	0.00281	CcSEcCtD
Aminosalicylic Acid—Purpura—Doxorubicin—pancreatic cancer	0.000468	0.0028	CcSEcCtD
Aminosalicylic Acid—Vomiting—Tamoxifen—pancreatic cancer	0.000463	0.00277	CcSEcCtD
Aminosalicylic Acid—Hypoglycaemia—Doxorubicin—pancreatic cancer	0.000462	0.00277	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Sunitinib—pancreatic cancer	0.00046	0.00275	CcSEcCtD
Aminosalicylic Acid—Rash—Tamoxifen—pancreatic cancer	0.000459	0.00275	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Tamoxifen—pancreatic cancer	0.000459	0.00275	CcSEcCtD
Aminosalicylic Acid—Vomiting—Erlotinib—pancreatic cancer	0.000458	0.00274	CcSEcCtD
Aminosalicylic Acid—Headache—Tamoxifen—pancreatic cancer	0.000456	0.00273	CcSEcCtD
Aminosalicylic Acid—Rash—Erlotinib—pancreatic cancer	0.000454	0.00272	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Erlotinib—pancreatic cancer	0.000454	0.00272	CcSEcCtD
Aminosalicylic Acid—Headache—Erlotinib—pancreatic cancer	0.000451	0.0027	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Doxorubicin—pancreatic cancer	0.000451	0.0027	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Irinotecan—pancreatic cancer	0.000447	0.00268	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000444	0.00266	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Docetaxel—pancreatic cancer	0.000435	0.00261	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Gemcitabine—pancreatic cancer	0.000435	0.00261	CcSEcCtD
Aminosalicylic Acid—Nausea—Tamoxifen—pancreatic cancer	0.000433	0.00259	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000432	0.00259	CcSEcCtD
Aminosalicylic Acid—Nausea—Erlotinib—pancreatic cancer	0.000428	0.00256	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Fluorouracil—pancreatic cancer	0.000428	0.00256	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Sunitinib—pancreatic cancer	0.000427	0.00256	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Docetaxel—pancreatic cancer	0.000426	0.00255	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000425	0.00255	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Epirubicin—pancreatic cancer	0.000424	0.00254	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00042	0.00252	CcSEcCtD
Aminosalicylic Acid—Dizziness—Sunitinib—pancreatic cancer	0.000412	0.00247	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Irinotecan—pancreatic cancer	0.000406	0.00243	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Irinotecan—pancreatic cancer	0.000406	0.00243	CcSEcCtD
Aminosalicylic Acid—Anaemia—Docetaxel—pancreatic cancer	0.000402	0.00241	CcSEcCtD
Aminosalicylic Acid—Vomiting—Sunitinib—pancreatic cancer	0.000397	0.00238	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Gemcitabine—pancreatic cancer	0.000396	0.00237	CcSEcCtD
Aminosalicylic Acid—Rash—Sunitinib—pancreatic cancer	0.000393	0.00236	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Sunitinib—pancreatic cancer	0.000393	0.00235	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Doxorubicin—pancreatic cancer	0.000392	0.00235	CcSEcCtD
Aminosalicylic Acid—Urticaria—Fluorouracil—pancreatic cancer	0.000391	0.00234	CcSEcCtD
Aminosalicylic Acid—Headache—Sunitinib—pancreatic cancer	0.000391	0.00234	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Docetaxel—pancreatic cancer	0.00039	0.00233	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Fluorouracil—pancreatic cancer	0.000389	0.00233	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Epirubicin—pancreatic cancer	0.000381	0.00228	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Irinotecan—pancreatic cancer	0.000379	0.00227	CcSEcCtD
Aminosalicylic Acid—Nausea—Sunitinib—pancreatic cancer	0.00037	0.00222	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000368	0.00221	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000368	0.0022	CcSEcCtD
Aminosalicylic Acid—Jaundice—Epirubicin—pancreatic cancer	0.000366	0.00219	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000363	0.00217	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Doxorubicin—pancreatic cancer	0.000353	0.00211	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Irinotecan—pancreatic cancer	0.000352	0.00211	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Epirubicin—pancreatic cancer	0.000351	0.0021	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Docetaxel—pancreatic cancer	0.000348	0.00209	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000348	0.00208	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Docetaxel—pancreatic cancer	0.000345	0.00207	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Gemcitabine—pancreatic cancer	0.000342	0.00205	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000341	0.00204	CcSEcCtD
Aminosalicylic Acid—Dizziness—Irinotecan—pancreatic cancer	0.00034	0.00204	CcSEcCtD
Aminosalicylic Acid—Jaundice—Doxorubicin—pancreatic cancer	0.000339	0.00203	CcSEcCtD
Aminosalicylic Acid—Anorexia—Docetaxel—pancreatic cancer	0.000339	0.00203	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Epirubicin—pancreatic cancer	0.000337	0.00202	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Fluorouracil—pancreatic cancer	0.000337	0.00202	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000333	0.00199	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Epirubicin—pancreatic cancer	0.000331	0.00198	CcSEcCtD
Aminosalicylic Acid—Vomiting—Irinotecan—pancreatic cancer	0.000327	0.00196	CcSEcCtD
Aminosalicylic Acid—Dizziness—Fluorouracil—pancreatic cancer	0.000325	0.00195	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000324	0.00194	CcSEcCtD
Aminosalicylic Acid—Rash—Irinotecan—pancreatic cancer	0.000324	0.00194	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Irinotecan—pancreatic cancer	0.000324	0.00194	CcSEcCtD
Aminosalicylic Acid—Headache—Irinotecan—pancreatic cancer	0.000322	0.00193	CcSEcCtD
Aminosalicylic Acid—Vomiting—Gemcitabine—pancreatic cancer	0.000318	0.00191	CcSEcCtD
Aminosalicylic Acid—Rash—Gemcitabine—pancreatic cancer	0.000316	0.00189	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Gemcitabine—pancreatic cancer	0.000315	0.00189	CcSEcCtD
Aminosalicylic Acid—Headache—Gemcitabine—pancreatic cancer	0.000314	0.00188	CcSEcCtD
Aminosalicylic Acid—Vomiting—Fluorouracil—pancreatic cancer	0.000313	0.00187	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Doxorubicin—pancreatic cancer	0.000312	0.00187	CcSEcCtD
Aminosalicylic Acid—Rash—Fluorouracil—pancreatic cancer	0.00031	0.00186	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Fluorouracil—pancreatic cancer	0.00031	0.00186	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Docetaxel—pancreatic cancer	0.000309	0.00185	CcSEcCtD
Aminosalicylic Acid—Headache—Fluorouracil—pancreatic cancer	0.000308	0.00185	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000308	0.00185	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000307	0.00184	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Doxorubicin—pancreatic cancer	0.000306	0.00183	CcSEcCtD
Aminosalicylic Acid—Nausea—Irinotecan—pancreatic cancer	0.000305	0.00183	CcSEcCtD
Aminosalicylic Acid—Nausea—Gemcitabine—pancreatic cancer	0.000297	0.00178	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Epirubicin—pancreatic cancer	0.000294	0.00176	CcSEcCtD
Aminosalicylic Acid—Nausea—Fluorouracil—pancreatic cancer	0.000292	0.00175	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.00029	0.00174	CcSEcCtD
Aminosalicylic Acid—Flatulence—Epirubicin—pancreatic cancer	0.000289	0.00173	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Epirubicin—pancreatic cancer	0.000287	0.00172	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Docetaxel—pancreatic cancer	0.000281	0.00168	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Docetaxel—pancreatic cancer	0.000281	0.00168	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Doxorubicin—pancreatic cancer	0.000272	0.00163	CcSEcCtD
Aminosalicylic Acid—Anaemia—Epirubicin—pancreatic cancer	0.000271	0.00163	CcSEcCtD
Aminosalicylic Acid—Flatulence—Doxorubicin—pancreatic cancer	0.000268	0.0016	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Doxorubicin—pancreatic cancer	0.000266	0.00159	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Epirubicin—pancreatic cancer	0.000263	0.00157	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Docetaxel—pancreatic cancer	0.000262	0.00157	CcSEcCtD
Aminosalicylic Acid—Anaemia—Doxorubicin—pancreatic cancer	0.000251	0.0015	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000248	0.00149	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Doxorubicin—pancreatic cancer	0.000243	0.00146	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Docetaxel—pancreatic cancer	0.000243	0.00146	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Epirubicin—pancreatic cancer	0.000235	0.00141	CcSEcCtD
Aminosalicylic Acid—Dizziness—Docetaxel—pancreatic cancer	0.000235	0.00141	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000235	0.00141	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Epirubicin—pancreatic cancer	0.000233	0.00139	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.00023	0.00138	CcSEcCtD
Aminosalicylic Acid—Anorexia—Epirubicin—pancreatic cancer	0.000228	0.00137	CcSEcCtD
Aminosalicylic Acid—Vomiting—Docetaxel—pancreatic cancer	0.000226	0.00135	CcSEcCtD
Aminosalicylic Acid—Rash—Docetaxel—pancreatic cancer	0.000224	0.00134	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Docetaxel—pancreatic cancer	0.000224	0.00134	CcSEcCtD
Aminosalicylic Acid—Headache—Docetaxel—pancreatic cancer	0.000222	0.00133	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000217	0.0013	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000217	0.0013	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Doxorubicin—pancreatic cancer	0.000215	0.00129	CcSEcCtD
Aminosalicylic Acid—Anorexia—Doxorubicin—pancreatic cancer	0.000211	0.00127	CcSEcCtD
Aminosalicylic Acid—Nausea—Docetaxel—pancreatic cancer	0.000211	0.00126	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Epirubicin—pancreatic cancer	0.000208	0.00125	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000207	0.00124	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000196	0.00117	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Doxorubicin—pancreatic cancer	0.000193	0.00115	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000191	0.00115	CcSEcCtD
Aminosalicylic Acid—Urticaria—Epirubicin—pancreatic cancer	0.00019	0.00114	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Epirubicin—pancreatic cancer	0.000189	0.00113	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Epirubicin—pancreatic cancer	0.000189	0.00113	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000181	0.00109	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Epirubicin—pancreatic cancer	0.000176	0.00106	CcSEcCtD
Aminosalicylic Acid—Urticaria—Doxorubicin—pancreatic cancer	0.000176	0.00105	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Doxorubicin—pancreatic cancer	0.000175	0.00105	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Doxorubicin—pancreatic cancer	0.000175	0.00105	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Epirubicin—pancreatic cancer	0.000164	0.000982	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000163	0.000978	CcSEcCtD
Aminosalicylic Acid—Dizziness—Epirubicin—pancreatic cancer	0.000158	0.000949	CcSEcCtD
Aminosalicylic Acid—Vomiting—Epirubicin—pancreatic cancer	0.000152	0.000913	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Doxorubicin—pancreatic cancer	0.000152	0.000909	CcSEcCtD
Aminosalicylic Acid—Rash—Epirubicin—pancreatic cancer	0.000151	0.000905	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Epirubicin—pancreatic cancer	0.000151	0.000904	CcSEcCtD
Aminosalicylic Acid—Headache—Epirubicin—pancreatic cancer	0.00015	0.000899	CcSEcCtD
Aminosalicylic Acid—Dizziness—Doxorubicin—pancreatic cancer	0.000147	0.000878	CcSEcCtD
Aminosalicylic Acid—Nausea—Epirubicin—pancreatic cancer	0.000142	0.000852	CcSEcCtD
Aminosalicylic Acid—Vomiting—Doxorubicin—pancreatic cancer	0.000141	0.000844	CcSEcCtD
Aminosalicylic Acid—Rash—Doxorubicin—pancreatic cancer	0.00014	0.000837	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Doxorubicin—pancreatic cancer	0.00014	0.000837	CcSEcCtD
Aminosalicylic Acid—Headache—Doxorubicin—pancreatic cancer	0.000139	0.000832	CcSEcCtD
Aminosalicylic Acid—Nausea—Doxorubicin—pancreatic cancer	0.000132	0.000789	CcSEcCtD
Aminosalicylic Acid—PTGS1—Metabolism—TYMP—pancreatic cancer	6.03e-05	0.000317	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	6.02e-05	0.000316	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—JAG1—pancreatic cancer	5.92e-05	0.000311	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—NFKBIA—pancreatic cancer	5.9e-05	0.00031	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IFNA1—pancreatic cancer	5.9e-05	0.00031	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—EGF—pancreatic cancer	5.88e-05	0.000309	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—HRAS—pancreatic cancer	5.86e-05	0.000308	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SCT—pancreatic cancer	5.86e-05	0.000308	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HEY1—pancreatic cancer	5.86e-05	0.000308	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	5.86e-05	0.000308	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—AKT1—pancreatic cancer	5.84e-05	0.000307	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—AKT1—pancreatic cancer	5.84e-05	0.000307	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—AKT1—pancreatic cancer	5.84e-05	0.000307	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	5.8e-05	0.000305	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—AKT1—pancreatic cancer	5.79e-05	0.000304	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—AKT1—pancreatic cancer	5.74e-05	0.000302	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—AKT1—pancreatic cancer	5.72e-05	0.0003	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—DTX4—pancreatic cancer	5.72e-05	0.0003	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TP53—pancreatic cancer	5.67e-05	0.000298	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	5.65e-05	0.000297	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—EGF—pancreatic cancer	5.65e-05	0.000297	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CD44—pancreatic cancer	5.62e-05	0.000295	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—EGFR—pancreatic cancer	5.62e-05	0.000295	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCK—pancreatic cancer	5.59e-05	0.000294	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—HSPA1A—pancreatic cancer	5.58e-05	0.000293	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PPP2R5B—pancreatic cancer	5.56e-05	0.000292	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	5.5e-05	0.000289	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—PIK3CA—pancreatic cancer	5.5e-05	0.000289	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IFNA2—pancreatic cancer	5.49e-05	0.000288	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ARG2—pancreatic cancer	5.48e-05	0.000288	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CNR2—pancreatic cancer	5.45e-05	0.000286	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—GLP1R—pancreatic cancer	5.45e-05	0.000286	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—AKT1—pancreatic cancer	5.41e-05	0.000284	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—KRAS—pancreatic cancer	5.4e-05	0.000283	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCKAR—pancreatic cancer	5.36e-05	0.000281	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HEY2—pancreatic cancer	5.35e-05	0.000281	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—KRAS—pancreatic cancer	5.3e-05	0.000279	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CDH1—pancreatic cancer	5.26e-05	0.000276	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	5.24e-05	0.000275	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—PIK3CD—pancreatic cancer	5.23e-05	0.000275	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—JAG2—pancreatic cancer	5.2e-05	0.000273	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—AKT1—pancreatic cancer	5.18e-05	0.000272	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MEN1—pancreatic cancer	5.12e-05	0.000269	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—APOE—pancreatic cancer	5.11e-05	0.000268	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	5.11e-05	0.000268	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—PIK3CD—pancreatic cancer	5.02e-05	0.000264	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	4.98e-05	0.000261	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—PIK3CA—pancreatic cancer	4.96e-05	0.00026	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HEY1—pancreatic cancer	4.96e-05	0.00026	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SHH—pancreatic cancer	4.88e-05	0.000257	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—PIK3CA—pancreatic cancer	4.87e-05	0.000256	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GLP1R—pancreatic cancer	4.86e-05	0.000255	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NOTCH4—pancreatic cancer	4.85e-05	0.000255	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.84e-05	0.000254	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IAPP—pancreatic cancer	4.82e-05	0.000253	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—TYMP—pancreatic cancer	4.79e-05	0.000251	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—DPYD—pancreatic cancer	4.78e-05	0.000251	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	4.7e-05	0.000247	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	4.69e-05	0.000246	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PTHLH—pancreatic cancer	4.63e-05	0.000243	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PTCH1—pancreatic cancer	4.63e-05	0.000243	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PIK3CG—pancreatic cancer	4.61e-05	0.000242	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	4.59e-05	0.000241	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—HRAS—pancreatic cancer	4.59e-05	0.000241	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—PIK3CB—pancreatic cancer	4.56e-05	0.000239	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—SLC2A2—pancreatic cancer	4.54e-05	0.000238	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—HRAS—pancreatic cancer	4.51e-05	0.000237	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—AKT1—pancreatic cancer	4.49e-05	0.000236	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	4.49e-05	0.000236	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PPARG—pancreatic cancer	4.45e-05	0.000234	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—SMAD4—pancreatic cancer	4.44e-05	0.000233	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—JAG2—pancreatic cancer	4.39e-05	0.000231	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—PIK3CB—pancreatic cancer	4.38e-05	0.00023	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	4.38e-05	0.00023	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	4.34e-05	0.000228	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—HES1—pancreatic cancer	4.33e-05	0.000228	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	4.33e-05	0.000228	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MEN1—pancreatic cancer	4.33e-05	0.000227	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SLC2A2—pancreatic cancer	4.3e-05	0.000226	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SST—pancreatic cancer	4.24e-05	0.000222	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—JAG1—pancreatic cancer	4.14e-05	0.000218	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SHH—pancreatic cancer	4.13e-05	0.000217	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NOTCH3—pancreatic cancer	4.13e-05	0.000217	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—IAPP—pancreatic cancer	4.08e-05	0.000214	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PIK3CD—pancreatic cancer	4.05e-05	0.000213	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CTNNB1—pancreatic cancer	4.04e-05	0.000212	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	3.99e-05	0.000209	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—AKT1—pancreatic cancer	3.98e-05	0.000209	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	3.95e-05	0.000207	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—BCL2L1—pancreatic cancer	3.95e-05	0.000207	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.95e-05	0.000207	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—PTEN—pancreatic cancer	3.94e-05	0.000207	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—TSC2—pancreatic cancer	3.92e-05	0.000206	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HSPA1B—pancreatic cancer	3.92e-05	0.000206	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CNR1—pancreatic cancer	3.91e-05	0.000205	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GLP1R—pancreatic cancer	3.86e-05	0.000203	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	3.86e-05	0.000203	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—TERT—pancreatic cancer	3.8e-05	0.000199	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—DPYD—pancreatic cancer	3.8e-05	0.000199	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—PTEN—pancreatic cancer	3.78e-05	0.000199	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—GCG—pancreatic cancer	3.78e-05	0.000198	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—SRC—pancreatic cancer	3.65e-05	0.000192	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—HIF1A—pancreatic cancer	3.63e-05	0.000191	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—TSC2—pancreatic cancer	3.62e-05	0.00019	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—SLC2A2—pancreatic cancer	3.6e-05	0.000189	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—AGTR1—pancreatic cancer	3.6e-05	0.000189	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—NFKBIA—pancreatic cancer	3.58e-05	0.000188	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	3.56e-05	0.000187	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—STK11—pancreatic cancer	3.55e-05	0.000186	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—APOE—pancreatic cancer	3.55e-05	0.000186	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PIK3CB—pancreatic cancer	3.53e-05	0.000186	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—NRAS—pancreatic cancer	3.52e-05	0.000185	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CD44—pancreatic cancer	3.51e-05	0.000185	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—SRC—pancreatic cancer	3.51e-05	0.000184	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—JAG1—pancreatic cancer	3.51e-05	0.000184	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PTGS2—pancreatic cancer	3.5e-05	0.000184	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.44e-05	0.000181	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	3.44e-05	0.000181	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—EGF—pancreatic cancer	3.43e-05	0.00018	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.41e-05	0.000179	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—NRAS—pancreatic cancer	3.38e-05	0.000177	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GCG—pancreatic cancer	3.37e-05	0.000177	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CD44—pancreatic cancer	3.33e-05	0.000175	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HSPA1A—pancreatic cancer	3.31e-05	0.000174	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NOTCH1—pancreatic cancer	3.27e-05	0.000172	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	3.26e-05	0.000171	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—EGFR—pancreatic cancer	3.2e-05	0.000168	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CDH1—pancreatic cancer	3.19e-05	0.000168	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—STK11—pancreatic cancer	3.17e-05	0.000166	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—EGF—pancreatic cancer	3.16e-05	0.000166	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.13e-05	0.000165	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SMAD4—pancreatic cancer	3.11e-05	0.000163	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—EGFR—pancreatic cancer	3.08e-05	0.000162	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PTEN—pancreatic cancer	3.05e-05	0.00016	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PIK3CD—pancreatic cancer	3.05e-05	0.00016	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HES1—pancreatic cancer	3.04e-05	0.000159	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—KRAS—pancreatic cancer	3.03e-05	0.000159	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.97e-05	0.000156	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—KRAS—pancreatic cancer	2.91e-05	0.000153	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PIK3CD—pancreatic cancer	2.81e-05	0.000148	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CD44—pancreatic cancer	2.79e-05	0.000147	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—PIK3CA—pancreatic cancer	2.78e-05	0.000146	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.73e-05	0.000143	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—TYMS—pancreatic cancer	2.72e-05	0.000143	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GCG—pancreatic cancer	2.67e-05	0.00014	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—PIK3CA—pancreatic cancer	2.67e-05	0.00014	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TERT—pancreatic cancer	2.66e-05	0.00014	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PIK3CB—pancreatic cancer	2.66e-05	0.000139	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SMAD4—pancreatic cancer	2.63e-05	0.000138	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—HRAS—pancreatic cancer	2.57e-05	0.000135	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HES1—pancreatic cancer	2.57e-05	0.000135	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HIF1A—pancreatic cancer	2.54e-05	0.000134	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TSC2—pancreatic cancer	2.54e-05	0.000133	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—STK11—pancreatic cancer	2.51e-05	0.000132	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—APOE—pancreatic cancer	2.48e-05	0.00013	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HRAS—pancreatic cancer	2.47e-05	0.00013	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PIK3CB—pancreatic cancer	2.45e-05	0.000129	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—KDR—pancreatic cancer	2.43e-05	0.000128	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PTGS2—pancreatic cancer	2.43e-05	0.000128	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.36e-05	0.000124	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CTNNB1—pancreatic cancer	2.35e-05	0.000124	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NFKBIA—pancreatic cancer	2.31e-05	0.000122	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PTEN—pancreatic cancer	2.29e-05	0.000121	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NOTCH1—pancreatic cancer	2.29e-05	0.00012	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—AKT1—pancreatic cancer	2.27e-05	0.000119	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TERT—pancreatic cancer	2.25e-05	0.000118	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PIK3CG—pancreatic cancer	2.24e-05	0.000118	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—APOE—pancreatic cancer	2.22e-05	0.000116	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—EGF—pancreatic cancer	2.22e-05	0.000116	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—AKT1—pancreatic cancer	2.18e-05	0.000115	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CTNNB1—pancreatic cancer	2.17e-05	0.000114	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—TYMS—pancreatic cancer	2.16e-05	0.000114	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PIK3CA—pancreatic cancer	2.15e-05	0.000113	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HIF1A—pancreatic cancer	2.15e-05	0.000113	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TSC2—pancreatic cancer	2.15e-05	0.000113	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—SRC—pancreatic cancer	2.13e-05	0.000112	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PTEN—pancreatic cancer	2.12e-05	0.000111	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—APOE—pancreatic cancer	2.1e-05	0.00011	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.1e-05	0.00011	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—STAT3—pancreatic cancer	2.05e-05	0.000108	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—NRAS—pancreatic cancer	2.05e-05	0.000108	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PIK3CG—pancreatic cancer	2e-05	0.000105	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PIK3CD—pancreatic cancer	1.97e-05	0.000103	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—SRC—pancreatic cancer	1.96e-05	0.000103	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NOTCH1—pancreatic cancer	1.94e-05	0.000102	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PPARG—pancreatic cancer	1.93e-05	0.000101	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—STAT3—pancreatic cancer	1.89e-05	9.95e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NRAS—pancreatic cancer	1.89e-05	9.93e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—EGF—pancreatic cancer	1.87e-05	9.84e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—EGFR—pancreatic cancer	1.87e-05	9.8e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—KRAS—pancreatic cancer	1.76e-05	9.26e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MYC—pancreatic cancer	1.76e-05	9.25e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—AKT1—pancreatic cancer	1.76e-05	9.24e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—APOE—pancreatic cancer	1.76e-05	9.24e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PIK3CD—pancreatic cancer	1.76e-05	9.23e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—TGFB1—pancreatic cancer	1.76e-05	9.23e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—EGFR—pancreatic cancer	1.72e-05	9.05e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PIK3CB—pancreatic cancer	1.72e-05	9.02e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PIK3CD—pancreatic cancer	1.67e-05	8.75e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.67e-05	8.74e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CXCL8—pancreatic cancer	1.65e-05	8.67e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—KRAS—pancreatic cancer	1.63e-05	8.55e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PIK3CA—pancreatic cancer	1.62e-05	8.5e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PIK3CG—pancreatic cancer	1.59e-05	8.34e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CASP3—pancreatic cancer	1.58e-05	8.29e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCND1—pancreatic cancer	1.54e-05	8.07e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PIK3CB—pancreatic cancer	1.53e-05	8.05e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PPARG—pancreatic cancer	1.53e-05	8.05e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CTNNB1—pancreatic cancer	1.52e-05	8e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PTGS2—pancreatic cancer	1.52e-05	7.97e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HRAS—pancreatic cancer	1.5e-05	7.87e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PIK3CA—pancreatic cancer	1.49e-05	7.85e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MMP9—pancreatic cancer	1.49e-05	7.84e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PTEN—pancreatic cancer	1.48e-05	7.79e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PIK3CB—pancreatic cancer	1.45e-05	7.63e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PIK3CD—pancreatic cancer	1.4e-05	7.33e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—HRAS—pancreatic cancer	1.38e-05	7.26e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SRC—pancreatic cancer	1.38e-05	7.23e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—VEGFA—pancreatic cancer	1.34e-05	7.04e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—STAT3—pancreatic cancer	1.33e-05	6.97e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PTEN—pancreatic cancer	1.32e-05	6.95e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NRAS—pancreatic cancer	1.32e-05	6.95e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—AKT1—pancreatic cancer	1.32e-05	6.95e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CTNNB1—pancreatic cancer	1.29e-05	6.76e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PTEN—pancreatic cancer	1.26e-05	6.59e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MYC—pancreatic cancer	1.23e-05	6.48e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TGFB1—pancreatic cancer	1.23e-05	6.46e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—AKT1—pancreatic cancer	1.22e-05	6.41e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PIK3CB—pancreatic cancer	1.22e-05	6.39e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—EGFR—pancreatic cancer	1.21e-05	6.33e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SRC—pancreatic cancer	1.16e-05	6.11e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—KRAS—pancreatic cancer	1.14e-05	5.98e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—STAT3—pancreatic cancer	1.12e-05	5.9e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NRAS—pancreatic cancer	1.12e-05	5.88e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PTEN—pancreatic cancer	1.05e-05	5.52e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PIK3CA—pancreatic cancer	1.05e-05	5.5e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MYC—pancreatic cancer	1.04e-05	5.48e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TGFB1—pancreatic cancer	1.04e-05	5.46e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—EGFR—pancreatic cancer	1.02e-05	5.36e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TP53—pancreatic cancer	1.01e-05	5.32e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HRAS—pancreatic cancer	9.68e-06	5.09e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—KRAS—pancreatic cancer	9.64e-06	5.06e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PIK3CA—pancreatic cancer	9.34e-06	4.91e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PIK3CA—pancreatic cancer	8.85e-06	4.65e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—AKT1—pancreatic cancer	8.55e-06	4.49e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HRAS—pancreatic cancer	8.19e-06	4.3e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—AKT1—pancreatic cancer	7.63e-06	4.01e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PIK3CA—pancreatic cancer	7.42e-06	3.89e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—AKT1—pancreatic cancer	7.23e-06	3.8e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—AKT1—pancreatic cancer	6.06e-06	3.18e-05	CbGpPWpGaD
